Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plant Derivative Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Plant Derivative Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plant Derivative Drug Market Perspective (2018-2029)
2.2 Plant Derivative Drug Growth Trends by Region
2.2.1 Global Plant Derivative Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plant Derivative Drug Historic Market Size by Region (2018-2024)
2.2.3 Plant Derivative Drug Forecasted Market Size by Region (2024-2029)
2.3 Plant Derivative Drug Market Dynamics
2.3.1 Plant Derivative Drug Industry Trends
2.3.2 Plant Derivative Drug Market Drivers
2.3.3 Plant Derivative Drug Market Challenges
2.3.4 Plant Derivative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plant Derivative Drug Players by Revenue
3.1.1 Global Top Plant Derivative Drug Players by Revenue (2018-2024)
3.1.2 Global Plant Derivative Drug Revenue Market Share by Players (2018-2024)
3.2 Global Plant Derivative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plant Derivative Drug Revenue
3.4 Global Plant Derivative Drug Market Concentration Ratio
3.4.1 Global Plant Derivative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plant Derivative Drug Revenue in 2022
3.5 Plant Derivative Drug Key Players Head office and Area Served
3.6 Key Players Plant Derivative Drug Product Solution and Service
3.7 Date of Enter into Plant Derivative Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plant Derivative Drug Breakdown Data by Type
4.1 Global Plant Derivative Drug Historic Market Size by Type (2018-2024)
4.2 Global Plant Derivative Drug Forecasted Market Size by Type (2024-2029)
5 Plant Derivative Drug Breakdown Data by Application
5.1 Global Plant Derivative Drug Historic Market Size by Application (2018-2024)
5.2 Global Plant Derivative Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plant Derivative Drug Market Size (2018-2029)
6.2 North America Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plant Derivative Drug Market Size by Country (2018-2024)
6.4 North America Plant Derivative Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plant Derivative Drug Market Size (2018-2029)
7.2 Europe Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plant Derivative Drug Market Size by Country (2018-2024)
7.4 Europe Plant Derivative Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plant Derivative Drug Market Size (2018-2029)
8.2 Asia-Pacific Plant Derivative Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plant Derivative Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Plant Derivative Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plant Derivative Drug Market Size (2018-2029)
9.2 Latin America Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plant Derivative Drug Market Size by Country (2018-2024)
9.4 Latin America Plant Derivative Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plant Derivative Drug Market Size (2018-2029)
10.2 Middle East & Africa Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plant Derivative Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Plant Derivative Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Plant Derivative Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2018-2024)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Plant Derivative Drug Introduction
11.2.4 China TCM Revenue in Plant Derivative Drug Business (2018-2024)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Plant Derivative Drug Introduction
11.3.4 Tsumura Revenue in Plant Derivative Drug Business (2018-2024)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Plant Derivative Drug Introduction
11.4.4 Schwabe Revenue in Plant Derivative Drug Business (2018-2024)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Plant Derivative Drug Introduction
11.5.4 Tong Ren Tang Revenue in Plant Derivative Drug Business (2018-2024)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Plant Derivative Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2018-2024)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2018-2024)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Plant Derivative Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Plant Derivative Drug Business (2018-2024)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Plant Derivative Drug Introduction
11.9.4 Tasly Holding Group Revenue in Plant Derivative Drug Business (2018-2024)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Plant Derivative Drug Introduction
11.10.4 Bionorica Se Revenue in Plant Derivative Drug Business (2018-2024)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Plant Derivative Drug Introduction
11.11.4 Huarun 999 Revenue in Plant Derivative Drug Business (2018-2024)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Plant Derivative Drug Introduction
11.12.4 Taiji Revenue in Plant Derivative Drug Business (2018-2024)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Plant Derivative Drug Introduction
11.13.4 Weleda Revenue in Plant Derivative Drug Business (2018-2024)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Plant Derivative Drug Introduction
11.14.4 Kwangdong Revenue in Plant Derivative Drug Business (2018-2024)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Plant Derivative Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2018-2024)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plant Derivative Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Plant Derivative Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Plant Derivative Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Plant Derivative Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Plant Derivative Drug Market Share by Region (2018-2024)
Table 8. Global Plant Derivative Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Plant Derivative Drug Market Share by Region (2024-2029)
Table 10. Plant Derivative Drug Market Trends
Table 11. Plant Derivative Drug Market Drivers
Table 12. Plant Derivative Drug Market Challenges
Table 13. Plant Derivative Drug Market Restraints
Table 14. Global Plant Derivative Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Plant Derivative Drug Market Share by Players (2018-2024)
Table 16. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Derivative Drug as of 2022)
Table 17. Ranking of Global Top Plant Derivative Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Plant Derivative Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plant Derivative Drug Product Solution and Service
Table 21. Date of Enter into Plant Derivative Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plant Derivative Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Plant Derivative Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Plant Derivative Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Plant Derivative Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Plant Derivative Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Plant Derivative Drug Revenue Market Share by Application (2018-2024)
Table 29. Global Plant Derivative Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Plant Derivative Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Plant Derivative Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Plant Derivative Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Plant Derivative Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Buchang Pharmaceuticals Company Detail
Table 47. Buchang Pharmaceuticals Business Overview
Table 48. Buchang Pharmaceuticals Plant Derivative Drug Product
Table 49. Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 50. Buchang Pharmaceuticals Recent Development
Table 51. China TCM Company Detail
Table 52. China TCM Business Overview
Table 53. China TCM Plant Derivative Drug Product
Table 54. China TCM Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 55. China TCM Recent Development
Table 56. Tsumura Company Detail
Table 57. Tsumura Business Overview
Table 58. Tsumura Plant Derivative Drug Product
Table 59. Tsumura Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 60. Tsumura Recent Development
Table 61. Schwabe Company Detail
Table 62. Schwabe Business Overview
Table 63. Schwabe Plant Derivative Drug Product
Table 64. Schwabe Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 65. Schwabe Recent Development
Table 66. Tong Ren Tang Company Detail
Table 67. Tong Ren Tang Business Overview
Table 68. Tong Ren Tang Plant Derivative Drug Product
Table 69. Tong Ren Tang Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 70. Tong Ren Tang Recent Development
Table 71. Jumpcan Pharmaceutical Company Detail
Table 72. Jumpcan Pharmaceutical Business Overview
Table 73. Jumpcan Pharmaceutical Plant Derivative Drug Product
Table 74. Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 75. Jumpcan Pharmaceutical Recent Development
Table 76. Guangzhou Baiyunshan Pharmaceutical Company Detail
Table 77. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 78. Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product
Table 79. Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 80. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 81. Yunnan Baiyao Company Detail
Table 82. Yunnan Baiyao Business Overview
Table 83. Yunnan Baiyao Plant Derivative Drug Product
Table 84. Yunnan Baiyao Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 85. Yunnan Baiyao Recent Development
Table 86. Tasly Holding Group Company Detail
Table 87. Tasly Holding Group Business Overview
Table 88. Tasly Holding Group Plant Derivative Drug Product
Table 89. Tasly Holding Group Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 90. Tasly Holding Group Recent Development
Table 91. Bionorica Se Company Detail
Table 92. Bionorica Se Business Overview
Table 93. Bionorica Se Plant Derivative Drug Product
Table 94. Bionorica Se Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 95. Bionorica Se Recent Development
Table 96. Huarun 999 Company Detail
Table 97. Huarun 999 Business Overview
Table 98. Huarun 999 Plant Derivative Drug Product
Table 99. Huarun 999 Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 100. Huarun 999 Recent Development
Table 101. Taiji Company Detail
Table 102. Taiji Business Overview
Table 103. Taiji Plant Derivative Drug Product
Table 104. Taiji Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 105. Taiji Recent Development
Table 106. Weleda Company Detail
Table 107. Weleda Business Overview
Table 108. Weleda Plant Derivative Drug Product
Table 109. Weleda Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 110. Weleda Recent Development
Table 111. Kwangdong Company Detail
Table 112. Kwangdong Business Overview
Table 113. Kwangdong Plant Derivative Drug Product
Table 114. Kwangdong Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 115. Kwangdong Recent Development
Table 116. GW Pharmaceuticals Company Detail
Table 117. GW Pharmaceuticals Business Overview
Table 118. GW Pharmaceuticals Plant Derivative Drug Product
Table 119. GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 120. GW Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plant Derivative Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Plant Derivative Drug Market Share by Type: 2022 VS 2029
Figure 3. Prescription Drug Features
Figure 4. OTC Features
Figure 5. Global Plant Derivative Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Plant Derivative Drug Market Share by Application: 2022 VS 2029
Figure 7. Cardiovascular Case Studies
Figure 8. Tumor Case Studies
Figure 9. Respiratory System Case Studies
Figure 10. Other Case Studies
Figure 11. Plant Derivative Drug Report Years Considered
Figure 12. Global Plant Derivative Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Plant Derivative Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Plant Derivative Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Plant Derivative Drug Market Share by Players in 2022
Figure 16. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Derivative Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Plant Derivative Drug Revenue in 2022
Figure 18. North America Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Plant Derivative Drug Market Share by Country (2018-2029)
Figure 20. United States Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Plant Derivative Drug Market Share by Country (2018-2029)
Figure 24. Germany Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Plant Derivative Drug Market Share by Region (2018-2029)
Figure 32. China Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Plant Derivative Drug Market Share by Country (2018-2029)
Figure 40. Mexico Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Plant Derivative Drug Market Share by Country (2018-2029)
Figure 44. Turkey Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Buchang Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 47. China TCM Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 48. Tsumura Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 49. Schwabe Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 50. Tong Ren Tang Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 51. Jumpcan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 52. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 53. Yunnan Baiyao Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 54. Tasly Holding Group Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 55. Bionorica Se Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 56. Huarun 999 Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 57. Taiji Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 58. Weleda Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 59. Kwangdong Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 60. GW Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed